Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
02/11/2014 | CA2717246C Use of quinoline and quinolizinone derivatives as chemotherapeutic agents |
02/11/2014 | CA2646383C Inhibitors of lethal factor protease of anthrax toxin |
02/11/2014 | CA2631241C Materials and methods for treating viral infections with a cysteamine compound |
02/11/2014 | CA2611401C Oxindoles as kinase inhibitors |
02/11/2014 | CA2560042C Hmb compositions and uses thereof |
02/11/2014 | CA2558513C Amorolfine patch for treating onychomycosis |
02/11/2014 | CA2531565C Production of poxviruses with adherent or non adherent avian cell lines |
02/11/2014 | CA2529265C Quinoline derivatives for the treatment of latent tuberculosis |
02/11/2014 | CA2498502C Recombinant clostridial toxin fragments with proteolytic activation |
02/11/2014 | CA2452946C Detection and diagnosis of transmissible spongiform encephalopathies |
02/11/2014 | CA2388045C Nucleic acid immunogenic compositions encoding hsp-antigen chimera |
02/11/2014 | CA2364500C Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use |
02/11/2014 | CA2357986C Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
02/06/2014 | WO2014022636A1 Broad spectrum inhibitors of the post proline cleaving enzymes for treatment of hepatitis c virus infections |
02/06/2014 | WO2014021540A1 Antimicrobial composition comprising filobasidium-suppressing agent derived from natural substance |
02/06/2014 | WO2014021455A1 Immune cell activation inhibitor and use thereof |
02/06/2014 | WO2014021389A1 Peptide capable of inhibiting mate activity |
02/06/2014 | WO2014021284A1 Anti-trichophytic adhesive patch |
02/06/2014 | WO2014021282A1 Antitrichophytosis solution for external use |
02/06/2014 | WO2014020610A1 Compositions and methods for the treatment of bone voids and open fractures |
02/06/2014 | WO2014019486A1 New application of patchouli oil |
02/06/2014 | WO2014019485A1 New application of pogostone |
02/06/2014 | WO2014019452A1 Physical antimicrobial method |
02/06/2014 | WO2014019344A1 Bridged ring compounds as hepatitis c virus (hcv) inhibitors and pharmaceutical applications thereof |
02/06/2014 | WO2014019282A1 Meropenem bulk drug, preparation method thereof and pharmaceutical composition containing same |
02/06/2014 | US20140038947 Therapeutic applications of pro-apoptotic benzodiazepines |
02/06/2014 | US20140037735 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
02/06/2014 | US20140037668 Combination neisserial compositions |
02/06/2014 | US20140037635 Methods of treatment using il-17e antagonists |
02/06/2014 | US20140037616 Immunoglobulin 1 |
02/06/2014 | US20140037589 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
02/05/2014 | EP2692861A1 Nucleic acid construct containing nucleic acid derived from genotype 1b hcv genome, hcv genome-replicating cells transfected with same, and method for producing infectious hcv particles |
02/05/2014 | EP2692742A1 Novel preparation technique for higher-order structure that exhibits anti-cellular effect |
02/05/2014 | EP2692727A2 Novel oxazolidinone derivative and medical composition containing same |
02/05/2014 | EP2692726A1 Anti-viral compounds |
02/05/2014 | EP2692346A1 An antiviral 1-phenyl-2,5-dibenzimidazol-5-yl-pyrrolidine derivative |
02/05/2014 | EP2691422A2 Methods and compositions for cytomegalovirus il-10 protein |
02/05/2014 | EP2691413A1 Macrocyclic compounds and methods for their production |
02/05/2014 | EP2691412A1 Macrocyclic compound and methods for its production |
02/05/2014 | EP2691409A1 Compounds and pharmaceutical compositions for the treatment of viral infections |
02/05/2014 | EP2691396A2 Enopeptins, uses thereof, and methods of synthesis thereto |
02/05/2014 | EP2691373A1 3-ureidoisoquinolin-8-yl derivatives |
02/05/2014 | EP2691095A2 Imidazolyl amide compounds and uses related thereto |
02/05/2014 | EP2691094A1 Alisporivir to treat hepatitis c virus infection |
02/05/2014 | EP2691091A1 Use of epigallocatechin gallate as an antiviral agent against infections by the hepatitis c virus |
02/05/2014 | EP2691088A1 Viral inhibitor composition for in vivo therapeutic use |
02/05/2014 | EP2691087A2 Pharmaceutical composition containing no, process for the preparation and use thereof |
02/05/2014 | CN103562210A Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
02/05/2014 | CN103562208A Tricyclic gyrase inhibitors |
02/05/2014 | CN103562199A Tripeptides incorporating deuterium as inhibitors of hepatitis c virus |
02/05/2014 | CN103561764A Adjuvant composition containing citrulline |
02/05/2014 | CN103561749A Vaginal composition based on alkyl polyglucosides |
02/05/2014 | CN103561739A Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections |
02/05/2014 | CN103561735A Medicinal preparation ''RENESSANS'' having an antibacterial, anti-ulcerous and immuno-modulating action |
02/05/2014 | CN103561732A Therapeutic compounds |
02/05/2014 | CN103561724A Pharmaceutical composition for administration to nails |
02/05/2014 | CN103556540A 纸张及其制备方法 Paper and its preparation method |
02/05/2014 | CN103556226A Cefathiamidine monocrystal |
02/05/2014 | CN103555766A Rabbit hemorrhagic disease virus-like particles as well as preparation method and application thereof |
02/05/2014 | CN103555746A Recombinant porcine circovirus type 2 virus-like particle, and preparation method and application thereof |
02/05/2014 | CN103555733A Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
02/05/2014 | CN103555730A Large yellow croaker tropomyosin gene as well as recombinant protein and application thereof |
02/05/2014 | CN103555726A Unmethylated CpG contained DNA sequence (CpG-DNA) and its application |
02/05/2014 | CN103555725A Sdf-i binding nucleic acids |
02/05/2014 | CN103555680A PRRSV (porcine reproductive and respiratory syndrome virus) virus-like particles with immunogenicity as well as preparation and application thereof |
02/05/2014 | CN103555671A Vibrio harveyi giant phage VP4B and application thereof |
02/05/2014 | CN103555669A 黄病毒疫苗 Flavivirus vaccines |
02/05/2014 | CN103555645A Resistance marker-free attenuated live vaccine against porcine contagious pleuropneumonia (PCP) and application thereof |
02/05/2014 | CN103555625A High-lysine yield bacillus subtilis PL83, preparation method and application |
02/05/2014 | CN103555613A Bacillus subtilis having antagonistic effect on Streptococcus agalactiae and application thereof |
02/05/2014 | CN103555604A Lactobacillus salivarius capable of inhibiting Candida albicans growth, and separation method thereof |
02/05/2014 | CN103554271A Conjugate of an antibody against CD4 and antifusogenic peptides |
02/05/2014 | CN103554267A Fusion protein with anti-bacterial function, its construction method and application |
02/05/2014 | CN103554254A Chicken egg yolk antibody resisting human A rotavirus as well as preparation method and application thereof |
02/05/2014 | CN103554246A Interferon alpha mutant and polyethylene glycol derivative thereof |
02/05/2014 | CN103554244A Active peptide inhibiting respiratory viral infection and application and preparation method thereof |
02/05/2014 | CN103554241A Recombinant protein ASPPR with immunoregulatory activity and application thereof |
02/05/2014 | CN103554235A RBD (receptor binding domain) segment in MERS-CoV (Middle East respiratory syndrome coronavirus) membrane protein and coding gene and application thereof |
02/05/2014 | CN103554232A Linear synthetic peptide G and antiviral application thereof |
02/05/2014 | CN103554225A Synthetic antibacterial peptides and application thereof |
02/05/2014 | CN103554222A Compounds for enzyme inhibition |
02/05/2014 | CN103554137A Preparation method of cefdinir micropowder |
02/05/2014 | CN103554111A Aromatic heterocyclic pyridine derivatives and analogs, and preparation method and application thereof |
02/05/2014 | CN103554104A Azaindoles useful as inhibitors of jak and other protein kinases |
02/05/2014 | CN103554103A Indole[3,2-c]quinoline compounds or pharmaceutically acceptable salts thereof, and preparation method and application thereof |
02/05/2014 | CN103554038A Polyhalogenated benzonitrile quinazolone compounds, preparation method and use thereof |
02/05/2014 | CN103553968A Cinnamic hydroxamic acid compounds and preparation method thereof |
02/05/2014 | CN103550820A Wound plaster |
02/05/2014 | CN103550812A Beautifying incense and preparation method thereof |
02/05/2014 | CN103550788A Health-care method for improving immune effect of livestock and poultry vaccine and reducing immunological stress |
02/05/2014 | CN103550779A Application of ethylene diamine tetraacetic acid disodium in veterinary drugs |
02/05/2014 | CN103550773A Multivalent combined vaccine |
02/05/2014 | CN103550772A Production method of pseudorabies virus vaccine |
02/05/2014 | CN103550771A Production method of transmissible gastroenteritis virus vaccine |
02/05/2014 | CN103550770A Preparation method of compound effervescent tablets for treating chicken infectious bursal disease |
02/05/2014 | CN103550769A Production method of porcine circovirus type 2 |
02/05/2014 | CN103550768A Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
02/05/2014 | CN103550767A Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
02/05/2014 | CN103550766A Production method of anti-helicobacter pylori (Hp) immune pasteurized milk |
02/05/2014 | CN103550765A Streptococcus iniae DNA (Deoxyribonucleic Acid) vaccine as well as application thereof |